ReviewCurrent atherosclerosis reports2026
RNA-Based Therapies for Lipoprotein(a) Reduction: Antisense Oligonucleotides, Small Interfering RNAs, and Emerging Platforms.
Vibhu Parcha et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.